DOGE cuts potentially hitting key FDA drug testing lab – report
by
Contributor since / Followers
Contributor since / Followers
1 month ago
The Department of Government Efficiency (DOGE) has hinted that it may shut a U.S. FDA
LLY
Amgen begins late-stage trials for obesity therapy
by
Contributor since / Followers
Contributor since / Followers
1 month ago
JHVEPhoto Amgen (NASDAQ:AMGN) has announced the beginning of two Phase 3 studies for its weight
Novo Nordisk launches NovoCare rivaling Eli Lilly’s LillyDirect
by
Contributor since / Followers
Contributor since / Followers
1 month ago
aprott/iStock via Getty Images Rivaling Eli Lilly’s (NYSE:LLY) direct-to-consumer platform LillyDirect, which made its market
Generic drugmakers could see negative impact from higher Chinese tariffs
by
Contributor since / Followers
Contributor since / Followers
1 month ago
Generic drugmakers could be significantly impacted by President Trump’s decision to double the tariff on
Play defense with Goldman’s cheap healthcare picks
by
Contributor since / Followers
Contributor since / Followers
1 month ago
stevecoleimages/E+ via Getty Images The Goldman Sachs equity team says it continues to recommend investors
4 stocks to watch on Friday: FUBO, ADSK, META and LLY
by
Contributor since / Followers
Contributor since / Followers
1 month ago
Justin Sullivan/Getty Images News U.S. stock index futures were largely higher on Friday, as market
Eli Lilly in pact with Magnet Bio to develop cancer drugs in a deal worth up to $1.25B
by
Contributor since / Followers
Contributor since / Followers
1 month ago
jetcityimage/iStock Editorial via Getty Images Magnet Biomedicine announced Friday it has reached a licensing agreement
Eli Lilly shares climb for seven consecutive sessions
by
Contributor since / Followers
Contributor since / Followers
2 months ago
Eli Lilly (NYSE:LLY) shares rose for seven straight sessions, as the stock ended 1.5% higher
Eli Lilly to boost U.S. manufacturing footprint amid Trump’s tariff threats
by
Contributor since / Followers
Contributor since / Followers
2 months ago
jetcityimage/iStock Editorial via Getty Images Eli Lilly (NYSE:LLY) announced plans to more than double its
Eli Lilly to acquire Organovo’s FXR program
by
Contributor since / Followers
Contributor since / Followers
2 months ago
JHVEPhoto San Diego, California-based biotech Organovo Holdings (NASDAQ:ONVO) announced Tuesday that Eli Lilly (NYSE:LLY) has